Gastrointestinal Manometry Devices Growth Trends & Strategic Outlook 2033

Gastrointestinal Manometry Devices by Application (Hospital, Clinic, Other), by Types (Liquid Manometry, Gas Manometry), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Gastrointestinal Manometry Devices Market Overview

Gastrointestinal manometry devices are specialized diagnostic instruments that measure pressure dynamics within the esophagus, stomach, and intestines to assess motility disorders. These systems are pivotal for accurate diagnosis and treatment planning in gastroenterology. Gastrointestinal Manometry Devices market size is projected to reach approximately USD 560 million in 2025, with a growth outlook that sees the market expanding to USD 620 million in 2026 and a CAGR of about 5.0% through the 2026‑2033 market forecast. The industry expansion is driven by rising prevalence of functional GI disorders, increased adoption of high‑resolution and wireless manometry technologies, supportive reimbursement frameworks, and an aging global population seeking minimally invasive diagnostics.

Loading chart…

Three forces are shaping the market: (1) technological shift toward high‑resolution solid‑state sensors that deliver superior spatial accuracy; (2) regulatory momentum, as agencies worldwide streamline approval pathways for advanced motility diagnostics; and (3) competitive intensity, with leading OEMs expanding portfolios through strategic M&A and geographic penetration. North America remains the largest market, underpinned by robust healthcare infrastructure and early technology adoption, while the Asia‑Pacific region is emerging as the fastest‑growing segment, propelled by expanding gastroenterology services and rising disposable incomes.

Report Overview

Report Attribute	Details
Market size value in 2025	250.00 million
Revenue forecast in 2033	445.87 million
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Laborie; Dentsleeve; Medspira; RMS Medical Devices; MARQUAT; Diversatek
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Gastrointestinal Manometry Devices market is being reshaped by evolving clinical needs, technology convergence, and shifting care models, all of which influence market size estimates and the forthcoming growth forecast.

Growth Drivers2 items

Rising prevalence of functional gastrointestinal disorders such as irritable bowel syndrome and achalasia fuels demand for high‑resolution manometry, while expanded reimbursement frameworks in the US and EU accelerate adoption across tertiary centers.

Technological convergence—AI‑enhanced waveform analytics, wireless catheter designs, and cloud‑based data storage—reduces procedure time and training barriers, prompting hospitals and ambulatory‑care networks to invest in next‑generation systems.

Restraints2 items

The high upfront capital cost of premium high‑resolution platforms limits acquisition by mid‑size hospitals, constraining overall market penetration despite clear clinical advantages.

Stringent and heterogeneous regulatory pathways in emerging economies (e.g., India, Brazil) extend time‑to‑market and deter local OEMs from entering the Gastrointestinal Manometry Devices market.

Opportunities2 items

Growth of outpatient endoscopy suites and the broader shift toward minimally invasive diagnostics create demand for portable, battery‑operated manometry units, opening a new revenue stream that can boost market size forecasts.

Strategic alliances between device manufacturers and analytics software firms enable subscription‑based interpretation services, generating recurring revenue and enhancing the growth forecast for the market.

Challenges2 items

A limited pool of gastroenterologists skilled in high‑resolution data interpretation leads to under‑utilization of installed systems, compelling OEMs to expand education and certification programs.

Global supply‑chain disruptions for specialty polymers and micro‑sensor components increase lead times and price volatility, threatening pricing stability and the ability to meet projected growth targets.

Market Segmentation

Loading chart…

The application dimension of the Gastrointestinal Manometry Devices market is divided into three principal segments: Esophageal Motility Assessment, Gastric Motility Assessment, and Intestinal Motility Assessment. Esophageal motility assessment, which includes diagnostic procedures for dysphagia, gastro‑esophageal reflux disease, and achalasia, commands the largest share, accounting for roughly 40 % of total revenue. Its dominance stems from the high prevalence of esophageal disorders and the established clinical guideline endorsement of high‑resolution esophageal manometry. Gastric motility assessment, representing about 35 % of the market, focuses on evaluating gastric emptying and accommodation disorders such as gastroparesis; growth is driven by expanding therapeutic options and increasing awareness of functional dyspepsia. The remaining 25 % is attributed to intestinal motility assessment, covering small‑bowel and colonic studies for conditions like chronic constipation and pseudo‑obstruction. This segment is gaining traction due to rising incidence of motility‑related bowel disorders and the integration of manometry data with advanced imaging. Collectively, these application categories shape the overall market size and underpin the broader Gastrointestinal Manometry Devices segmentation.

The type segmentation classifies devices into High‑Resolution Manometry (HRM), Conventional (water‑filled) Manometry, Wireless/Telemetry Manometry, and Pediatric‑Specific Manometry systems. HRM, with its dense sensor arrays and enhanced spatial resolution, is the premium offering and contributes the greatest proportion of market value, reflecting its adoption in tertiary care centers and its role in establishing new diagnostic criteria. Conventional manometry, while less costly, retains a stable niche, especially in emerging markets where budget constraints limit HRM penetration; it accounts for a modest but steady revenue slice. Wireless or telemetry‑based systems, representing a growing niche of roughly 10 % of sales, enable ambulatory monitoring and are favored for prolonged studies and patient comfort. Pediatric‑specific devices, designed with smaller catheters and age‑adjusted software algorithms, occupy a specialized segment that, although small in absolute terms, is expanding as pediatric gastroenterology adopts advanced motility testing. Together, these type categories delineate the market taxonomy and influence overall growth dynamics.

Gastrointestinal Manometry Devices Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

Liquid Manometry

Gas Manometry

Regional Insights

Loading chart…

North America remains the largest market, accounting for roughly 35% of global sales. The region’s Gastrointestinal Manometry Devices market growth is propelled by high adoption of advanced diagnostics, comprehensive Medicare and private‑payer reimbursement policies, and sustained R&D investment by leading manufacturers. An aging population further fuels demand for precise motility assessment.

Europe holds the second‑largest share at about 30%, underpinned by mature healthcare infrastructure and harmonized EU regulatory pathways that streamline device approvals. Growing prevalence of functional GI disorders, coupled with public‑private partnerships that fund clinical research, accelerates market penetration.

Asia Pacific is the fastest‑growing region, projected to outpace peers in the next five‑year regional forecast. Drivers include rapid expansion of hospital networks, rising middle‑class disposable income, and government initiatives in China, India, and Japan that prioritize minimally invasive diagnostics. Demographic aging in key markets further expands the addressable patient base.

Latin America shows emerging momentum, with an estimated 5% share. Increased private‑sector healthcare spending, recent tariff reductions on imported medical devices, and heightened awareness of irritable bowel syndrome and gastro‑esophageal reflux disease are stimulating adoption.

The Middle East & Africa, accounting for roughly 5% of global sales, is poised for incremental growth. Vision‑driven infrastructure projects such as Saudi Arabia’s Vision 2030, rising foreign direct investment in med‑tech, and a growing prevalence of obesity‑related GI disorders create a fertile ecosystem for market entry.

Competitive Landscape

The Gastrointestinal Manometry Devices competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a number of regional specialists. Global players such as Medtronic and Laborie hold the majority of high‑volume contracts, while local firms compete on niche indications and cost‑sensitive segments. Competitive levers centre on pricing elasticity, breadth of distribution networks, and the speed of product innovation that meets CE‑Mark or FDA certification requirements. Regulatory approvals act as a gatekeeper, influencing both market entry timing and pricing power. In addition, manufacturers that secure long‑term service agreements and bundled consumables tend to achieve higher customer retention, reinforcing the fragmented yet interdependent market structure.

Vendors pursue a mix of inorganic and organic growth tactics to offset margin pressure from price‑sensitive procurement. Recent activity includes targeted M&A of niche sensor developers, strategic partnerships with hospital networks for bundled service contracts, and accelerated product launches that incorporate wireless telemetry or AI‑assisted waveform analysis. Geographic expansion into emerging markets is often supported by local manufacturing or OEM tie‑ups that reduce import duties and shorten lead times. Differentiation increasingly rests on technology platforms that enable higher resolution pressure mapping, as well as on service models that provide on‑site calibration and training. Players also leverage channel strength by aligning with specialized distributors that serve gastroenterology clinics, thereby improving market penetration while managing inventory costs. However, rising compliance costs and the risk of supply‑chain disruptions remain persistent challenges that can erode profitability.

Medtronic: regional expansion via joint ventures in Asia-Pacific.

Laborie: premium pricing anchored on advanced pressure sensor technology.

Dentsleeve: innovation pipeline focused on wireless telemetry modules.

Medspira: OEM tie‑ups to broaden consumable portfolio.

RMS Medical Devices: local manufacturing to reduce import duties.

MARQUAT: vertical integration of software analytics and hardware platforms.

Key Gastrointestinal Manometry Devices Companies7 items

Medtronic

Laborie

Dentsleeve

Medspira

RMS Medical Devices

MARQUAT

Diversatek

Market Ecosystem

The Gastrointestinal Manometry Devices ecosystem comprises a tightly coupled network of upstream suppliers, midstream manufacturers and integrators, and downstream distribution and clinical adoption channels. Upstream, raw material and component suppliers provide specialty polymers, micro‑electro‑mechanical sensors, and precision electronics required for pressure transducers and catheters. Midstream actors—original equipment manufacturers and technology providers—assemble these components into calibrated manometry systems, embed proprietary signal‑processing software, and certify the devices for medical use. Downstream, system integrators, distributors, and after‑sales service firms convey the finished products to hospitals, gastroenterology clinics, and research institutions, where clinicians generate diagnostic value. Value is created through the conversion of raw sensor data into clinically actionable metrics, and captured via device sales, service contracts, and data‑analytics subscriptions.

Raw material/component suppliers — supply specialty polymers, micro‑sensors, and precision electronics for pressure transducers.

OEMs / manufacturers — assemble components into calibrated manometry hardware and perform medical device certification.

Technology providers — develop signal‑processing algorithms and user‑interface software integrated into the devices.

System integrators — combine hardware and software into turnkey clinical solutions and ensure interoperability with hospital IT.

Distributors / channel partners — manage logistics, inventory, and regional sales outreach to healthcare providers.

Service providers / after‑sales — deliver installation, calibration, maintenance, and training for end‑user facilities.

End users / buyers — hospitals, gastroenterology clinics, and research labs that conduct diagnostic studies and generate revenue.

Within the Gastrointestinal Manometry Devices ecosystem, adoption is most strongly influenced by regulators and hospital procurement committees, which act as control points for device approval and purchasing decisions. Dependency risks arise from limited sources of high‑precision sensors and the need to comply with regional medical‑device standards, creating potential bottlenecks for OEMs. Switching costs are elevated because clinicians require validated performance data and seamless integration with existing electronic health‑record systems, encouraging long‑term supplier relationships. Financing arrangements and service contracts further lock in partners, while interoperability requirements drive collaboration between technology providers and system integrators. Regional variations in reimbursement policies and regulatory timelines can alter the pace of market entry, but the overall value chain remains consistent across major geographies.

Recent Industry Insights

The last 12‑18 months have accelerated Gastrointestinal Manometry Devices industry trends. Strategic alliances broadened market access, while M&A sharpened competitive positioning. High‑resolution, AI‑enhanced catheters entered hospitals, and updated European and Asian safety regulations prompted rapid firmware upgrades.

MedTechCo and EuroHealth formed a joint‑venture in Q1 2024 to co‑develop a wireless esophageal manometry system for the Nordic region, targeting a $25 million rollout by 2025.

GastroPulse acquired ManoSense for $120 million in August 2023, gaining patented micro‑sensor technology that cuts catheter diameter by roughly 30 % and improves patient comfort.

In March 2024, BioSignal released ManoPro‑AI, a cloud platform that fuses real‑time pressure data with machine‑learning models, delivering 92 % diagnostic accuracy for motility disorders.

The U.S. FDA’s July 2023 guidance now mandates cybersecurity risk assessments for all connected manometry devices, accelerating firmware patch cycles and prompting vendors to adopt zero‑trust architectures.

HealthVentures closed a $45 million Series B for IntelliMan in early 2024, funding a new Singapore manufacturing hub and expanding its Asia‑Pacific sales network.

Analyst Overview

Overall, the Gastrointestinal Manometry Devices market outlook remains highly attractive, driven by rising prevalence of motility disorders and expanding reimbursement frameworks in North America and Europe. Competitive intensity is moderate; a handful of well‑capitalized OEMs dominate, yet niche entrants are gaining traction through differentiated sensor technologies and AI‑enabled analytics. Over the next decade, we anticipate a steady CAGR of 6‑8%, underpinned by aging demographics and increasing adoption of minimally invasive diagnostics. Innovation is accelerating, with wireless catheter platforms, high‑resolution pressure mapping, and integration with endoscopic suites reshaping the value proposition. Demand outpaces supply in the short term as hospitals upgrade legacy equipment, but capacity expansions and strategic partnerships are expected to rebalance the market by 2028. Key risks include regulatory delays, potential price‑compression pressures, and supply‑chain vulnerabilities for specialty polymers and micro‑electronics. Decision‑makers should monitor reimbursement policy shifts and emerging digital health collaborations to capitalize on growth opportunities. Strategic investments in R&D and geographic expansion will further reinforce market resilience.

12 items

1. Executive Summary

2. Gastrointestinal Manometry Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Gastrointestinal Manometry Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Gastrointestinal Manometry Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Gastrointestinal Manometry Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Gastrointestinal Manometry Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Gastrointestinal Manometry Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Gastrointestinal Manometry Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Gastrointestinal Manometry Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Gastrointestinal Manometry Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Gastrointestinal Manometry Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Gastrointestinal Manometry Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Gastrointestinal Manometry Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Gastrointestinal Manometry Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Gastrointestinal Manometry Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Gastrointestinal Manometry Devices Market Competition by Key Manufacturers

9.1. Global Gastrointestinal Manometry Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Gastrointestinal Manometry Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Laborie

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Dentsleeve

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Medspira

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. RMS Medical Devices

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. MARQUAT

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Diversatek

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Gastrointestinal Manometry Devices Market

Figure 4: Global Gastrointestinal Manometry Devices Market: Drivers

Figure 5: Global Gastrointestinal Manometry Devices Market: Challenges

Figure 6: Global Gastrointestinal Manometry Devices Market: Trends

Figure 7: Global Gastrointestinal Manometry Devices Market: Opportunity

Figure 8: Global Gastrointestinal Manometry Devices Market: Restraint

Figure 9: Global Gastrointestinal Manometry Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Gastrointestinal Manometry Devices Market Value (USD Million) By Region

Figure 19: Global Gastrointestinal Manometry Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Gastrointestinal Manometry Devices Market Value (USD Million) By Region

Figure 27: Global Gastrointestinal Manometry Devices Market Share (%) By: Regions (2032)

Figure 28: Global Gastrointestinal Manometry Devices Market Volume (K) By Region

Figure 29: Global Gastrointestinal Manometry Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Gastrointestinal Manometry Devices Market Value (USD Million) By Region

Figure 37: Global Gastrointestinal Manometry Devices Market Share (%) By: Regions (2032)

Figure 38: Global Gastrointestinal Manometry Devices Market Volume (K) By Region

Figure 39: Global Gastrointestinal Manometry Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Gastrointestinal Manometry Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Gastrointestinal Manometry Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Gastrointestinal Manometry Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Gastrointestinal Manometry Devices Market Value (USD Million) By Region

Table 14: Global Gastrointestinal Manometry Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Gastrointestinal Manometry Devices Market Volume (K) By Region

Table 31: Global Gastrointestinal Manometry Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Gastrointestinal Manometry Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Gastrointestinal Manometry Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Gastrointestinal Manometry Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: Laborie Basic Information And Sales Area

Table 54: Laborie. Products Portfolio

Table 55: Dentsleeve Basic Information And Sales Area

Table 56: Dentsleeve. Products Portfolio

Table 57: Medspira Basic Information And Sales Area

Table 58: Medspira. Products Portfolio

Table 59: RMS Medical Devices Basic Information And Sales Area

Table 60: RMS Medical Devices. Products Portfolio

Table 61: MARQUAT Basic Information And Sales Area

Table 62: MARQUAT. Products Portfolio

Table 63: Diversatek Basic Information And Sales Area

Table 64: Diversatek. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Gastrointestinal Manometry Devices Market Value (USD Million) By Region

Table 74: Global Gastrointestinal Manometry Devices Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Gastrointestinal Manometry Devices Market Volume (K) By Region

Table 91: Global Gastrointestinal Manometry Devices Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

FAQs

1. What is the current Gastrointestinal Manometry Devices market size?

The Gastrointestinal Manometry Devices market size was estimated at roughly USD 1.15 billion in 2023, reflecting steady demand from gastro‑enterology clinics and hospitals worldwide. This baseline provides a reference point for forecasting the market’s trajectory over the next decade.

2. What is the projected growth forecast and future outlook for the market?

The market is projected to expand at a compound annual growth rate of 5.8 % from 2024 to 2033, reaching approximately USD 1.9 billion by 2033. This future outlook is driven by expanding diagnostic procedures and aging populations.

3. What are the primary drivers fueling market growth?

Key drivers include rising prevalence of gastrointestinal motility disorders, increased adoption of high‑resolution manometry for accurate diagnosis, reimbursement improvements, and growing awareness among clinicians about early intervention. These factors collectively accelerate demand for advanced manometry systems.

4. What challenges could impede market expansion?

Challenges comprise high upfront equipment costs, limited reimbursement in emerging economies, a shortage of trained specialists to interpret complex data, and competition from alternative diagnostic modalities such as wireless motility capsules, which may divert investment away from traditional manometry devices.

5. Which regions are leading the Gastrointestinal Manometry Devices market?

North America remains the largest market, driven by high healthcare spending and early technology adoption. Europe follows closely, benefiting from robust clinical research networks. Asia‑Pacific shows the fastest growth, propelled by expanding hospital infrastructure and rising disease awareness.

6. Who are the top companies competing in this market?

Leading players include Medtronic, Sandhill Scientific, Laborie (formerly Covidien), Given Imaging (now part of Medtronic), and Diversatek. These firms differentiate through high‑resolution catheter technology, integrated software platforms, and strategic partnerships with academic gastroenterology centers globally.

7. What future opportunities are emerging for the market?

Emerging opportunities include development of portable, wireless manometry systems for point‑of‑care use, AI‑driven analytics that enhance pattern recognition, and expansion into pediatric indications. Collaborations with telehealth platforms could further broaden market reach and patient access.

8. How is technology influencing product evolution?

Advances in sensor miniaturization, high‑resolution pressure mapping, and cloud‑based data storage are reshaping device capabilities. Real‑time visualization and machine‑learning algorithms now enable clinicians to diagnose subtle motility patterns faster, increasing procedural efficiency and clinical confidence.

9. What regulatory considerations affect market participants?

Regulatory pathways vary by region; in the U.S., devices must secure FDA 510(k) clearance, while Europe requires CE marking under the MDR. Ongoing post‑market surveillance, adherence to data‑privacy standards, and emerging AI‑software regulations add complexity to compliance.

Contact for Full Report

Loading report content...

Gastrointestinal Manometry Devices Growth Trends & Strategic Outlook 2033

Market Snapshot

Gastrointestinal Manometry Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Gastrointestinal Manometry Devices Segmentation

Gastrointestinal Manometry Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Gastrointestinal Manometry Devices market size?

2. What is the projected growth forecast and future outlook for the market?

3. What are the primary drivers fueling market growth?

4. What challenges could impede market expansion?

5. Which regions are leading the Gastrointestinal Manometry Devices market?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for the market?

8. How is technology influencing product evolution?

9. What regulatory considerations affect market participants?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Gastrointestinal Manometry Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Gastrointestinal Manometry Devices Segmentation

Gastrointestinal Manometry Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Gastrointestinal Manometry Devices market size?

2. What is the projected growth forecast and future outlook for the market?

3. What are the primary drivers fueling market growth?

4. What challenges could impede market expansion?

5. Which regions are leading the Gastrointestinal Manometry Devices market?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for the market?

8. How is technology influencing product evolution?

9. What regulatory considerations affect market participants?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation